[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR910000743A - 티에노피란 유도체, 이의 제조방법 및 용도 - Google Patents

티에노피란 유도체, 이의 제조방법 및 용도 Download PDF

Info

Publication number
KR910000743A
KR910000743A KR1019900009322A KR900009322A KR910000743A KR 910000743 A KR910000743 A KR 910000743A KR 1019900009322 A KR1019900009322 A KR 1019900009322A KR 900009322 A KR900009322 A KR 900009322A KR 910000743 A KR910000743 A KR 910000743A
Authority
KR
South Korea
Prior art keywords
compound
formula
radical
integer
membrane
Prior art date
Application number
KR1019900009322A
Other languages
English (en)
Inventor
빈더 디터
로벤스즈키 프란쯔
빈베르거 요세프
페터 페르버 후베르트
Original Assignee
트론트 야콥센
케미쉬 파마조이티쉐 포르슝스게젤샤프트 엠. 베. 하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 트론트 야콥센, 케미쉬 파마조이티쉐 포르슝스게젤샤프트 엠. 베. 하 filed Critical 트론트 야콥센
Publication of KR910000743A publication Critical patent/KR910000743A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

티에노피란 유도체, 이의 제조방법 및 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (17)

  1. 하기 일반식(Ⅰ)의 화합물.
  2. 상기 식에서, 라디칼
  3. 중의 하나를 나타내고, R은 수소 또는 라디칼-CN, -CHO, -CH=NOH, -CONH2또는 -COOR1를 나타내며, R1은 라디칼(C1-C4)-알킬을 나타내고, n은 3, 4 또는 5의 정수이다.
  4. 제1항에 있어서, 트란스-6, 7-디하이드로-5, 5-디메틸-6-하이드록시-7-(2-옥소-1-피톨리디닐)-5H-티에노〔3, 2-b〕피란-2-카보니트릴인 화합물.
  5. 제1항에 있어서, 트란스-6, 7-디하이드로-5, 5-디메틸-6-하이드록시-7-(2-옥소-1-피톨리디닐)-5H-티에노〔3, 2-b〕피란-2-카보니트릴인 화합물.
  6. 제1항에 있어서, 순수한 에난티오며 형태로 존재하는 화합물.
  7. 제1항에 있어서, 광학적 대장체의 혼합물 형태로 존재하는 화합물.
  8. 2당량 이상의 비친핵성 강염기의 존재하에 불활성 유기 희석제중에서 일반식(Ⅲ)의 화합물을 일반식(Ⅳ)의 화합물과 반응시키고, 경우에 따라, 수득된 라세미체를 에난티오머로 분리시킴을 특징으로 하여, 제1항에 따른 일반식(Ⅰ)의 화합물을 제조하는 방법.
  9. 상기 식에서, 라디칼
  10. 중의 하나를 나타내고, X는 염소, 브롬 또는 요오드를 나타내고, n은 3,4 또는 5의 정수이다.
  11. 막 K+채널을 활성화시켜 완화 또는 치료할 수 있는 질병을 치료하기에 유효한 양의 일반식(Ⅰ)의 화합물과 함께 약제학적으로 허용되는 부형제, 담체 또는 희석제를 포함하는 약제학적 조성물.
  12. 환자에게 일반식(Ⅰ)의 화합물의 유효량을 투여함을 특징으로 하여, 막 K+채널을 활성화시켜 완화 또는 치료할 수 있는 질병을 치료하는 방법.
  13. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것
KR1019900009322A 1989-06-27 1990-06-23 티에노피란 유도체, 이의 제조방법 및 용도 KR910000743A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT157389 1989-06-27
AT1573/89 1989-06-27

Publications (1)

Publication Number Publication Date
KR910000743A true KR910000743A (ko) 1991-01-30

Family

ID=3516340

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900009322A KR910000743A (ko) 1989-06-27 1990-06-23 티에노피란 유도체, 이의 제조방법 및 용도

Country Status (28)

Country Link
US (1) US5077307A (ko)
EP (1) EP0405298B1 (ko)
KR (1) KR910000743A (ko)
CN (1) CN1025621C (ko)
AT (1) ATE105559T1 (ko)
AU (1) AU628995B2 (ko)
CA (1) CA2019737A1 (ko)
CZ (1) CZ280543B6 (ko)
DD (1) DD295850A5 (ko)
DE (1) DE59005666D1 (ko)
DK (1) DK0405298T3 (ko)
ES (1) ES2053015T3 (ko)
FI (1) FI96312C (ko)
HR (1) HRP940819A2 (ko)
HU (1) HU204834B (ko)
IE (1) IE63935B1 (ko)
IL (1) IL94703A (ko)
LT (1) LT3799B (ko)
LV (1) LV10776A (ko)
MD (1) MD121C2 (ko)
NO (1) NO174423C (ko)
NZ (1) NZ234084A (ko)
PT (1) PT94487B (ko)
RU (1) RU1833386C (ko)
SK (1) SK278012B6 (ko)
UA (1) UA15930A (ko)
YU (1) YU124690A (ko)
ZA (1) ZA904885B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents
DE3925719A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Substituierte thienopyranone, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von parasiten
NZ240933A (en) * 1990-12-21 1993-05-26 Ortho Pharma Corp Preparing enantiomerically pure thienopyran derivatives
GB9909792D0 (en) * 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
MD149Z5 (ro) * 2009-09-17 2010-09-30 Сергей Чербарь Sigiliu cu fibre optice din polimer
MD4034C2 (ro) * 2009-11-03 2010-11-30 Сергей Чербарь Sigiliu indicator pentru dispozitive metrologice
MD4230C1 (ro) * 2012-11-29 2013-12-31 Фёдор СЫРБУ Sigiliu
MD861Z (ro) * 2014-06-03 2015-07-31 Александр КОРЕНКОВ Sigiliu
MD4534C1 (ro) * 2017-03-03 2018-06-30 Сергей Чербарь Sigiliu cu rotor blocabil pentru dispozitive metrologice

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274350D1 (en) * 1981-09-25 1987-01-08 Beecham Group Plc Pharmaceutically active benzopyran compounds
GB8308062D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds
DE3682331D1 (de) * 1985-06-08 1991-12-12 Beecham Group Plc Pyrano(3,2-c)pyridinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
GB8613786D0 (en) * 1986-06-06 1986-07-09 Beecham Group Plc Active compounds
EP0277611B1 (de) * 1987-02-04 1993-06-16 Hoechst Aktiengesellschaft Alkylsubstituierte N-Benzopyranyllactame, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
US4789525A (en) * 1987-06-22 1988-12-06 Eastman Kodak Company Analytical method and multilayer element for total ionic iron determination
NZ230711A (en) * 1988-09-23 1990-10-26 Ortho Pharma Corp Substituted thienopyrans as antihypertensive agents

Also Published As

Publication number Publication date
LT3799B (en) 1996-03-25
FI903172A0 (fi) 1990-06-25
IE902097L (en) 1990-12-27
IL94703A (en) 1994-07-31
EP0405298A1 (de) 1991-01-02
AU628995B2 (en) 1992-09-24
CN1048388A (zh) 1991-01-09
DD295850A5 (de) 1991-11-14
CZ317290A3 (en) 1995-10-18
DE59005666D1 (de) 1994-06-16
FI96312B (fi) 1996-02-29
IE63935B1 (en) 1995-06-28
CA2019737A1 (en) 1990-12-27
NZ234084A (en) 1992-03-26
LTIP1590A (en) 1995-06-26
IE902097A1 (en) 1991-01-02
NO902832D0 (no) 1990-06-26
SK317290A3 (en) 1995-10-11
LV10776A (lv) 1995-08-20
IL94703A0 (en) 1991-04-15
CN1025621C (zh) 1994-08-10
HRP940819A2 (en) 1996-08-31
AU5778790A (en) 1991-01-03
US5077307A (en) 1991-12-31
CZ280543B6 (cs) 1996-02-14
NO902832L (no) 1990-12-28
MD121B1 (ro) 1994-12-31
HU204834B (en) 1992-02-28
UA15930A (uk) 1997-06-30
DK0405298T3 (da) 1994-06-06
YU124690A (en) 1991-10-31
NO174423B (no) 1994-01-24
NO174423C (no) 1994-05-04
FI96312C (fi) 1996-06-10
ES2053015T3 (es) 1994-07-16
PT94487A (pt) 1991-02-08
PT94487B (pt) 1997-02-28
ZA904885B (en) 1991-03-27
EP0405298B1 (de) 1994-05-11
SK278012B6 (en) 1995-10-11
MD121C2 (ro) 1995-06-30
HUT55787A (en) 1991-06-28
ATE105559T1 (de) 1994-05-15
HU903998D0 (en) 1990-11-28
RU1833386C (ru) 1993-08-07

Similar Documents

Publication Publication Date Title
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
DE59310085D1 (de) Indolocarbazol-imide und deren verwendung
AU572497B2 (en) 1,2,3,4-tetrahydro-2-naphthylamines
KR910000743A (ko) 티에노피란 유도체, 이의 제조방법 및 용도
DK0534445T3 (da) Fremgangsmåde til fremstilling af et lægemiddel til oral eller topisk administrering ved behandling af Leishmaniasis
AU584235B2 (en) New tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing them
CA2312842A1 (en) Taurine derivatives useable in the treatment of ophthalmic disorders
ATE59647T1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
KR890700131A (ko) 신규 화합물
KR910002456A (ko) 당뇨병 치료용 제약 조성물
OA09451A (fr) "Nouveaux dérivés de la pyrrolidone, leur procédé de préparation et les compositions pharmaceutiques les renfermant".
KR870007098A (ko) 플루오르화 디아미노알킨유도체 및 이의 제조방법
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
ATE965T1 (de) Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE56705T1 (de) Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
KR910004603A (ko) 신규 화합물
KR940003937A (ko) 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드
TH8604A (th) กระบวนการสำหรับทำอนุพันธ์ไธอีโนพัยแรนชนิดใหม่
TH5989A (th) นิวคลีโอไซด์ที่ใช้รักษาโรค
ATE283834T1 (de) Phenantrenderivate mit medizinischer anwendung sowie dessen herstellungsverfahren
FR2394528A1 (fr) Nouveaux analogues de prostaglandines et medicament les contenant
GB2316406A (en) Free radical scavenger molecules
KR910018347A (ko) 술포닐알칸산 아미드 유도체
KR950017956A (ko) N-치환 아자비시클로헵탄 유도체, 그의 제조 방법 및 용도

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application